GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sds Optic SA (WAR:SDS) » Definitions » ROCE %

Sds Optic (WAR:SDS) ROCE % : -100.26% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sds Optic ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sds Optic's annualized ROCE % for the quarter that ended in Dec. 2024 was -100.26%.


Sds Optic ROCE % Historical Data

The historical data trend for Sds Optic's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sds Optic ROCE % Chart

Sds Optic Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial 0.21 -22.45 -103.10 -131.07 -123.25

Sds Optic Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -122.67 -90.97 -69.10 -68.31 -100.26

Sds Optic ROCE % Calculation

Sds Optic's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-9.235/( ( (7.947 - 1.182) + (8.89 - 0.669) )/ 2 )
=-9.235/( (6.765+8.221)/ 2 )
=-9.235/7.493
=-123.25 %

Sds Optic's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=-9.372/( ( (11.212 - 0.737) + (8.89 - 0.669) )/ 2 )
=-9.372/( ( 10.475 + 8.221 )/ 2 )
=-9.372/9.348
=-100.26 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sds Optic  (WAR:SDS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Sds Optic ROCE % Related Terms

Thank you for viewing the detailed overview of Sds Optic's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sds Optic Business Description

Traded in Other Exchanges
N/A
Address
ul. Gleboka 39, Centrum Ecotech-Complex, Block A, Lublin, POL, 20-612
Sds Optic SA is engaged in developing and creating solutions on the borderline of biochemistry, engineering and fiber optic technologies, used in cancer diagnosis and treatment. The company has designed an Opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. The company is also focused on manufacturing Optoelectronics.

Sds Optic Headlines

From GuruFocus

PIERSHALE FINANCIAL GROUP, INC. Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 10-26-2022

Psagot Value Holdings Ltd. / (Israel) Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-09-2022

PIERSHALE FINANCIAL GROUP, INC. Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-13-2023